KROS-301

N/A

Report date: 2023/09/05 15:53:57
NME

Base Information

Drug NameKROS-301
Drug Alias NameKROS301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCedars-Sinai Medical CenterKairos Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCedars-Sinai Medical CenterKairos Pharma Ltd
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A